Hôpital St. Louis

Paris 75475

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia, Head and Neck Cancer, Higher-Risk Myelodysplastic Syndrome (HR-MDS), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Myelodysplastic Syndrome, Newly Diagnosed Intermediate/High-Risk MDS, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations, Relapsed/Refractory Multiple Myeloma (RRMM)

Studies at this site

• Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed
• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed
• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed
• Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q) — Completed
• Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine — Completed